Related references
Note: Only part of the references are listed.Quantification of Viral Proteins of the Avian H7 Subtype of Influenza Virus: An Isotope Dilution Mass Spectrometry Method Applicable for Producing more Rapid Vaccines in the Case of an Influenza Pandemic
Wanda I. Santana et al.
ANALYTICAL CHEMISTRY (2014)
Development of a High-Yield Live Attenuated H7N9 Influenza Virus Vaccine That Provides Protection against Homologous and Heterologous H7 Wild-Type Viruses in Ferrets
Zhongying Chen et al.
JOURNAL OF VIROLOGY (2014)
Compensatory Hemagglutinin Mutations Alter Antigenic Properties of Influenza Viruses
Jaclyn L. Myers et al.
JOURNAL OF VIROLOGY (2013)
Structural Analysis of the Hemagglutinin from the Recent 2013 H7N9 Influenza Virus
Hua Yang et al.
JOURNAL OF VIROLOGY (2013)
Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses
Di Liu et al.
LANCET (2013)
Molecular Signature of High Yield (Growth) Influenza A Virus Reassortants Prepared as Candidate Vaccine Seeds
Manojkumar Ramanunninair et al.
PLOS ONE (2013)
Preferential Recognition of Avian-Like Receptors in Human Influenza A H7N9 Viruses
Rui Xu et al.
SCIENCE (2013)
Antigenic Drift of the Pandemic 2009 A(H1N1) Influenza Virus in a Ferret Model
Teagan Guarnaccia et al.
PLOS PATHOGENS (2013)
Receptor-Binding Profiles of H7 Subtype Influenza Viruses in Different Host Species
Alexandra S. Gambaryan et al.
JOURNAL OF VIROLOGY (2012)
Increased hemagglutinin content in a reassortant 2009 pandemic H1N1 influenza virus with chimeric neuraminidase containing donor A/Puerto Rico/8/34 virus transmembrane and stalk domains
Xianghong Jing et al.
VACCINE (2012)
Gene Constellation of Influenza A Virus Reassortants with High Growth Phenotype Prepared as Seed Candidates for Vaccine Production
Andrew A. Fulvini et al.
PLOS ONE (2011)
Improvement of H5N1 influenza vaccine viruses: Influence of internal gene segments of avian and human origin on production and hemagglutinin content
Marion Abt et al.
VACCINE (2011)
The development of vaccine viruses against pandemic A(H1N1) influenza
James S. Robertson et al.
VACCINE (2011)
Identification of amino acid residues of influenza A virus H3 HA contributing to the recognition of molecular species of sialic acid
Tadanobu Takahashi et al.
FEBS LETTERS (2009)
Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production
Jie Dong et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2009)
Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift
Scott E. Hensley et al.
SCIENCE (2009)
Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine
Samadhan J. Jadhao et al.
VACCINE (2008)
Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1)
Ruth Harvey et al.
VACCINE (2008)
Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry
Tracie L. Williams et al.
VACCINE (2008)
Vaccine manufacturing: challenges and solutions
Jeffrey B. Ulmer et al.
NATURE BIOTECHNOLOGY (2006)
Eight-plasmid system for rapid generation of influenza virus vaccines
E Hoffmann et al.
VACCINE (2002)
Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics
R Wagner et al.
JOURNAL OF VIROLOGY (2000)
Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus
LJ Mitnaul et al.
JOURNAL OF VIROLOGY (2000)